Investment
Features
FeesSafety
Academy
More
Pluang+

Compare ADMA Biologics Inc (ADMA) vs Docusign Inc (DOCU) Price & Performance

ADMA Biologics IncTrade
Docusign IncTrade

Price performance (Past 24H)

Key statistics

ADMA Biologics Inc vs Docusign Inc — how do they compare? ADMA Biologics Inc trades at $9.81 (market cap $2.22B), while Docusign Inc trades at $58.39 (market cap $11.33B). The key difference: Docusign Inc is far larger — about 5.1× ADMA Biologics Inc's market cap, and Docusign Inc is trading nearer its 52-week high, ADMA Biologics Inc nearer its low. Which is the better fit depends on your goals.

ADMADOCU
Market Cap
$2.22B$11.33B
Sector
HealthTechnology
52-Week High
$20.38$85.01
52-Week Low
$7.60$41.75
Enterprise Value
$2.29B$10.70B

Returns comparison

Trailing returns across standard periods

About ADMA Biologics Inc

ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.

Read more on ADMA

About Docusign Inc

DocuSign offers the Agreement Cloud, a broad cloud-based software suite that enables users to automate the agreement process and provide legally binding e-signatures from nearly any device. The company was founded in 2003 and completed its IPO in May 2018.

Read more on DOCU